US equities
|
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Anthony Mack
Recent news which mentions Anthony Mack
Lab Notes: Lannett files FDA application for new drug; Virpax to start clinical trial for knee pain drug candidate
December 23, 2021
Tickers
INNO
Tags
Anthony Mack
Lannett Co/ Inc/
Inno
From
Business Journals
Virpax Pharmaceuticals prices $40M public stock offering
September 15, 2021
Tags
Anthony Mack
Health Care
Virpax Pharmaceuticals
From
Business Journals
Why Virpax Pharmaceuticals Stock Is Trading Higher Today
August 26, 2021
Tickers
VRPX
Tags
VRPX
Benzinga
why it's moving
From
Benzinga
Why Virpax Pharmaceuticals Shares Are Soaring Today
August 17, 2021
Tickers
VRPX
Tags
Benzinga
VRPX
Movers
From
Benzinga